Calnexin promotes glioblastoma progression by inducing protective mitophagy through the MEK/ERK/BNIP3 pathway

Xuchen Liu, Jiangli Zhao, Zhiwei Xue, Ziyi Tang, Wenyu Liu, Junzhi Liu, Nan‐Wei Su, Yuehua Zhu, Bin Huang, Ning Yang,

Theranostics · 2025 · 13 citations · 0 references

DOIFull text

Open access

Concepts

Abstract

Our findings indicate that CANX functions as an oncogene in GBM. We also characterize the CANX/MEK/ERK/BNIP3 mitophagy pathway, provide new insights into the molecular mechanism of GBM drug resistance, and identify a therapeutic target.